MedPath

A Comparison of a Fully Covered Self-expandable Metal Stent With an External Anchoring Plastic Stent and Uncovered Stent

Not Applicable
Recruiting
Conditions
Malignant Biliary Obstruction
Interventions
Device: uncovered self-expandable metal stent
Device: fully covered self-expandable metal stent with an anchoring external plastic stent
Registration Number
NCT05220475
Lead Sponsor
Seoul National University Hospital
Brief Summary

Multi-center, randomized controlled study fc-SEMS with anchoring plastic stent vs uc-SEMS in malignant biliary obstruction

Detailed Description

This study is multi-center, randomized controlled study to compare the stent patency in malignant biliary obstruction. The patency of fully covered self expandable metal stent with external anchoring plastic stent was compared with that of uncovered self expandable metal stent.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
108
Inclusion Criteria
  • Adults with 19 years of age or older
  • Those who voluntarily consented to the trial and signed a written consent
  • Inoperable malignant biliary obstruction
Exclusion Criteria
  • Previous surgical biliary drainage
  • Patients continuosly requiring percutaneous transhepatic biliary drainage
  • History of biliary drainage with metal stent
  • Biliary obstruction located in hilum or intrahepatic duct
  • Patients with life expectancy of 3 months or less
  • On pregnancy
  • Unable to underwent endoscopic procedures

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
uc-SEMSuncovered self-expandable metal stentuncovered self-expandable metal stent
fc-SEMS with anchoring plastic stentfully covered self-expandable metal stent with an anchoring external plastic stentfully covered self-expanable metal stent with an external anchoring plastic stent
Primary Outcome Measures
NameTimeMethod
Rate of patent stent1 year

The number of patient without stent dysfuction divided by total number of patients

Secondary Outcome Measures
NameTimeMethod
Stent migration1 year

Radiologic finding of migration through Abdomen X-ray or CT scan

Stent obstruction1 year

Suspected by jaundice (Total bilirubin \> 2 upper normal limit) or radiologic finding of stent occlusion which is confirmed by ERCP

Overall survival1 year

Timespan from the diagnosis to the death

Re-intervention1 year

Endoscopic retrograde biliary drainage or Percutaneous transhepatic biliary drainage

Adverse event1 year

acute cholangitis, acute cholecystitis, acute pancreatitis

Trial Locations

Locations (1)

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath